Pros and cons of using interleukin-2 receptor antibodies in liver transplant recipients

Liver Transpl. 2002 Feb;8(2):143-5. doi: 10.1053/jlts.2002.31384.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Hepatitis C / epidemiology
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Receptors, Interleukin-2 / immunology*
  • Recombinant Fusion Proteins*
  • Recurrence

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins
  • Basiliximab